Stock listing

Stockholm:VICO Vicore Pharma Holding AB Aktie

Home listing (Stockholm) of Vicore Pharma Holding AB

Follow Vicore Pharma Holding AB into a list and get an email when it puts out news.

Share price · OMXSTO:VICO

8.79 SEK -0.02 (-0.2%)

Close on Oct 19, 2026

Past 3 months -34.9% · daily closes, Jul 6, 2026 – Oct 19, 2026, adjusted for splits
Day range
8.73 – 9.08 SEKOct 19, 2026
Volume
938,598 sharesOct 19, 2026
Market cap
2.48B SEKAt the close on Oct 19, 2026 · price × 281.6M shares outstanding
Vicore Pharma Holding AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:VICO · Home8.79 SEK-0.02 (-0.2%)938,5988.999.088.738.81Close on Oct 19, 2026
Frankfurt:6Y4€0.782 EUR-0.018 (-2.3%)—€0.782€0.782€0.782€0.800Close on Oct 19, 2026
NASDAQ:VCRE$8.85 USD-0.13 (-1.4%)3,600$8.86$8.86$8.82$8.98Close on Oct 19, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 19, 2026 · OMXSTO:VICO · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
8.79-0.02-0.2%8.999.088.73938,598
8.81-0.10-1.1%8.939.048.78855,848
8.91-0.07-0.8%8.989.178.82875,238
8.98+0.12+1.4%8.909.198.761,045,132
8.86-0.29-3.2%9.209.248.831,570,710
9.15+0.15+1.7%9.029.448.643,818,030
9.00+0.30+3.4%9.459.648.932,082,044
8.70-0.02-0.2%8.608.908.561,199,701
8.72-0.24-2.7%8.888.958.721,045,305
8.96+0.07+0.8%8.989.288.90924,178
8.89-0.43-4.6%9.339.578.891,034,559
9.32-0.09-1.0%9.429.469.22827,373
9.41-0.17-1.8%9.569.629.39931,012
9.58+0.19+2.0%9.659.689.47697,774
9.39-0.09-0.9%9.489.689.39763,703
9.48-0.12-1.2%9.619.679.44690,944
9.60+0.05+0.5%9.619.819.56580,734
9.55-0.28-2.8%9.849.859.511,044,126
9.83-0.43-4.2%10.2410.269.83661,522
10.26+0.12+1.2%10.1010.289.961,157,772
10.14+0.04+0.4%10.1210.3210.04673,281
10.10-0.22-2.1%10.3410.4810.06607,606
10.32+0.18+1.8%10.1010.3810.10580,449
10.14-0.12-1.2%10.3010.3410.00660,688
10.26-0.34-3.2%10.7410.8810.26782,693
10.60+0.10+1.0%10.5010.8410.48579,640
10.50-0.56-5.1%11.0811.0810.501,272,877
11.06-0.34-3.0%11.5011.5411.06733,901
11.40-0.02-0.2%11.5411.7011.121,244,150
11.42+0.42+3.8%11.0811.5610.861,046,224
11.00+0.10+0.9%11.0211.1610.80621,995
10.900.000.0%11.2011.3410.881,066,880
10.90+0.18+1.7%10.9611.3210.76822,829
10.72+0.02+0.2%10.7610.9410.36974,369
10.70+0.38+3.7%10.8611.2010.621,730,140
10.32-0.26-2.5%10.6010.7010.30818,152
10.58-0.18-1.7%10.8010.8610.58513,610
10.76+0.10+0.9%10.7010.9210.66819,616
10.66-0.08-0.7%10.7210.8010.56436,984
10.74+0.14+1.3%10.6410.8810.541,224,280
10.60-0.40-3.6%10.9811.1010.501,157,503
11.00-0.04-0.4%10.9011.2010.72966,568
11.04-0.08-0.7%11.0011.2410.94321,717
11.12+0.04+0.4%11.0411.1610.90798,145
11.08-0.38-3.3%11.3611.6411.06639,167
11.46+0.26+2.3%11.2011.5811.14667,624
11.20-0.48-4.1%11.7611.8011.14892,582
11.68-0.06-0.5%11.7412.1011.64451,253
11.74+0.28+2.4%11.4411.7811.26294,108
11.46+0.20+1.8%11.2411.6811.20383,470
11.26-0.20-1.7%11.4011.7611.18525,758
11.46-0.04-0.3%11.5211.9411.46532,819
11.50+0.32+2.9%11.1011.5611.08390,326
11.18+0.10+0.9%11.0811.2810.84622,923
11.08+0.32+3.0%10.8811.1010.68368,941
10.76-0.36-3.2%11.1411.2810.66430,680
11.12+0.10+0.9%11.0411.5011.02461,835
11.02+0.20+1.8%10.8011.0210.74250,932
10.82-0.26-2.3%11.0611.1610.74580,759
11.08-0.20-1.8%11.3011.3011.02470,034
11.28+0.06+0.5%11.1011.4611.06434,349
11.22+0.04+0.4%11.1811.3811.06233,103
11.18-0.18-1.6%11.6211.6211.06402,817
11.36-0.10-0.9%11.4811.5011.24385,321
11.46+0.16+1.4%11.3011.5411.18342,921
11.30-0.06-0.5%11.3611.5611.22259,146
Ticker
Stockholm:VICO
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Stockholm
Currency
SEK

What changed lately

Latest news

Vicore Pharma to Present in The Stifel 2026 Virtual Immunology and Inflammation Forum

Sep 17, 2026

Closed 10.32 (+1.8%) on Sep 17, 2026

Vicore Pharma Appoints Rob Slack as Chief Scientific Officer

Jul 6, 2026

Vicore Pharma to Commence Trading in the United States on The Nasdaq Stock Market

Jul 1, 2026

Vicore Pharma Pursues US Dual Listing, Files Registration Statement with the SEC

May 22, 2026

Vicore Pharma Elects Peter Guenter to its Board of Directors

May 7, 2026

Announcement from the Annual General Meeting of Vicore Pharma Holding AB (publ)

May 6, 2026

Vicore Pharma Announces Presentations at the 2026 American Thoracic Society International Conference

Apr 29, 2026

Vicore Pharma Completes Enrollment in the Phase 2b ASPIRE Trial of Buloxibutid in Idiopathic Pulmonary Fibrosis

Apr 22, 2026

Notice Of Annual General Meeting In Vicore Pharma Holding AB (PUBL)

Apr 1, 2026

Vicore Publishes the Annual Report for 2025

Mar 26, 2026

All Vicore Pharma Holding AB news

Decks

Vicore Pharma Holding AB on 6ix

Sector
Health care
Industry
Biotechnology
News releases
25 in the last 12 months · 34 in all · newest Sep 17, 2026 · oldest 2025
Decks
21 decks · latest October 2026

Where Vicore Pharma Holding AB is listed

ListingExchangeCountryCurrency
Stockholm:VICO · Home listing · This pageStockholmSwedenSEK
gettex:6Y4gettexGermanyEUR
Lang & Schwarz:A14W4WLang & SchwarzGermanyEUR
LS Exchange:A14W4WLS ExchangeGermanyEUR
Aquis:VICOSAquisUnited KingdomSEK
Aquis:VICOSAquisUnited KingdomSEK
Dusseldorf:6Y4DusseldorfGermanyEUR
Frankfurt:6Y4FrankfurtGermanyEUR
Stuttgart:6Y4StuttgartGermanyEUR
Hamburg:6Y4HamburgGermanyEUR
Tradegate:6Y4TradegateGermanyEUR
NASDAQ:VCRENASDAQUnited StatesUSD

Log in to ask 6ix AI your own questions about Vicore Pharma Holding AB.